What went wrong at CVS?
Pharmacy chains are in crisis
The pharmacy industry is in crisis. That's especially true at CVS, where layoffs are piling on top of layoffs — and the future of the company is in question.
CVS Health announced this month that it is laying off 2,000 workers, CNN said, as part of an effort to "slash costs" across the company. That's on top of the 5,000 layoffs it announced last year, and after the company closed around 900 stores in recent years. CVS and other drug store chains are "struggling" due to falling reimbursement rates for prescription drugs, CNN said. "Our industry faces continued disruption, regulatory pressures and evolving consumer needs and expectations," said a company spokesperson.
What did the commentators say?
CVS' problems are also "very specific to the company," said Axios. In addition to its pharmacies, CVS is also a "major insurer" — it bought Aetna in 2017 — as well as a pharmacy benefit manager. Yes, "retail pharmacy in general is struggling," but CVS' challenges "could just be the specific businesses it has combined," Axios said. That's why company leaders are reportedly considering breaking up those businesses — an extraordinary move in an era where "vertical integration is all the rage."
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.
Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
"Satisfaction with brick-and-mortar pharmacies dropped 10 points in 2024," said Time. Customers report short-staffed outlets with "long lines and frustrating experiences." It's not just CVS: Rite Aid recently emerged from bankruptcy, and Walgreens is planning to close one-fourth of its roughly 8,600 stores. Customers simply didn't return to brick-and-mortar stores after the pandemic, preferring cheaper online alternatives. "The current pharmacy model is not sustainable," Walgreens CEO Tim Wentworth said in June.
That affects communities. The mass closure of retail pharmacies is a "growing worry for health experts," said the Missouri Independent. The problem is "most acute" in places with low incomes — "urban cores" and rural areas where pharmacies are the "convenience stores of the health care system." That makes getting necessary medications a growing challenge for the people who live in those places. "When those community pharmacies close, communities lose critical access," said one expert.
One other factor in the struggles of CVS and its industry: "Heavy competition" from Amazon and Walmart, said the Los Angeles Times. Pharmacy benefit managers (PBMs) also play a role — they have "significant control" over how much insurers pay pharmacies for medications and have worked to push down those reimbursement costs. That pushes down pharmacy profitability. One irony: CVS owns Caremark, a PBM. "That's made the drug retail business more healthy," said one analyst — but it still hasn't made CVS "immune to market forces," said the Times.
What next?
CVS' board is looking at "splitting the company," said The Wall Street Journal. That could be difficult. The spun-off businesses "might struggle to flourish on their own." The mergers with Aetna and Caremark were supposed to "bring down costs and give patients more convenient, accessible care." That didn't pan out. Now the future of the company is in limbo, the Journal said: CVS' board "isn't expected to make a decision soon."
Sign up for Today's Best Articles in your inbox
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Joel Mathis is a writer with 30 years of newspaper and online journalism experience. His work also regularly appears in National Geographic and The Kansas City Star. His awards include best online commentary at the Online News Association and (twice) at the City and Regional Magazine Association.
-
5 inflammatory cartoons on the L.A. wildfires
Cartoons Artists take on climate change denial, the blame game, and more
By The Week US Published
-
The problems with the current social care system
The Explainer The question of how to pay for adult social care is perhaps the greatest unresolved policy issue of our time
By The Week UK Published
-
Austria's new government: poised to join Putin's gang
Talking Point Opening for far-right Freedom Party would be a step towards 'the Putinisation of central Europe'
By The Week UK Published
-
The decline of the contraceptive pill
In the Spotlight Fears of the pill's side effects, stoked by social media, behind switch to fertility trackers – or no contraception at all
By Harriet Marsden, The Week UK Published
-
Walking pneumonia cases are picking up pace
The explainer Another respiratory illness to be wary of
By Devika Rao, The Week US Published
-
Drugmakers paid pharmacy benefit managers to avoid restricting opioid prescriptions
Under the radar The middlemen and gatekeepers of insurance coverage have been pocketing money in exchange for working with Big Pharma
By Theara Coleman, The Week US Published
-
California declares bird flu emergency
Speed Read The emergency came hours after the nation's first person with severe bird flu infection was hospitalized
By Rafi Schwartz, The Week US Published
-
The future of fluoridated water is up for debate
The Explainer The oral benefits are watery
By Devika Rao, The Week US Published
-
Will the murder of a health insurance CEO cause an industry reckoning?
Today's Big Question UnitedHealthcare CEO Brian Thompson was shot and killed in what police believe was a targeted attack
By Justin Klawans, The Week US Published
-
Bird flu one mutuation from human threat, study finds
Speed Read A Scripps Research Institute study found one genetic tweak of the virus could enable its spread among people
By Peter Weber, The Week US Published
-
Dark chocolate tied to lower diabetes risk
Speed Read The findings were based on the diets of about 192,000 US adults over 34 years
By Peter Weber, The Week US Published